United States: California Bill May Upend Pharma Company Interaction With HCPs

Last Updated: June 9 2017
Article by Kathleen McDermott, Michele Buenafe and Jacob J. Harper

The law would prohibit most gifts to healthcare professionals and providers.

Earlier this month, the California Senate passed SB 790, a bill that, if enacted, could dramatically change the landscape of interactions between physicians and pharmaceutical companies in the state. Among other things, this bill would prohibit pharma companies from offering or paying any gifts to physicians. The bill broadly defines the term "gift" as "anything of value provided for free to a health care provider" or "a payment, food, entertainment, travel, subscription, advance, service, or anything else of value provided to a health care provider, unless it is an 'allowable expenditure' or the health care provider reimburses the cost at fair market value."

If a pharmaceutical manufacturer cannot fit a payment made to a physician into an "allowable expenditure," it may be liable for a civil penalty of up to $10,000 for each violation of the law, as well as costs and attorney fees. This rule will be enforced by the California Attorney General.

Citing studies that suggest that physicians who receive industry payments are more likely to prescribe brand-name drugs at an exceptionally higher rate—two to three times more—than other physicians in their specialties, the authors of this bill seek to substantially change prescribing practices by ostensibly de-incentivizing healthcare providers. The legislative comments to this bill assert that the United States spends $73 billion annually on brand-name prescription drugs for which generic equivalents are available, resulting in approximately $24 billion in unnecessary overpayments for these products. These comments also assert that "[physician] interaction with the pharmaceutical industry" is associated with several negative consequences, including patient safety risks, drug cost increases, less availability of generic drugs, and less attention paid to evidence-based prescribing practices.

SB 790 would limit financial interactions between pharma and healthcare providers to "allowable expenditures." These allowable expenditures include the following:

  • Conferences. Payment to the sponsor of a significant educational, medical, scientific, or policy conference, so long as that payment is not made directly to a healthcare professional or pharmacist and the funding is used solely for bona fide educational purposes, except that the funding may also be used for meals and food for conference participants. The content of these conferences must be objective and free from industry control, and must not promote specific products.
  • Honoraria. Honoraria and expense reimbursement for healthcare professionals who serve on the faculty of a bona fide educational, medical, scientific, or policy conference, so long as these payments are governed by an explicit contract with specific deliverables that are restricted to medical issues, not marketing activities. The content of any presentation, including slides and written materials, must be determined by the healthcare professional.
  • Salary Support for Clinical Trials. For a bona fide clinical trial, payment of annual direct salary support for principal investigators and other healthcare professionals.
  • Compensation and Expenses for Systematic Investigations. For research projects that constitute systematic investigations, are designed to develop or contribute to general knowledge, and can be reasonably considered to be of significant interest or value to scientists or healthcare professionals within that field, payment of gross compensation, direct salary support for healthcare professionals, and expense reimbursement.
  • Royalties and Licensing Fees. Royalties and licensing fees paid to a healthcare provider in return for contractual rights to use or purchase a patented discovery owned by the healthcare provider.
  • Interview Expense Reimbursement. Expense reimbursement for manufacturer interview of healthcare professionals in connection with a bona fide employment opportunity or for the provision of healthcare services to employees of the manufacturer.
  • Meals. The provision of meals for healthcare providers not to exceed $250 per provider annually.

Notably, the bill introduces a definitional difference between "health care professional" and "health care provider." The latter term includes "health care professionals" but also includes hospitals, nursing homes, pharmacists, health plans, or other entities authorized to dispense or purchase for distribution prescription drugs. The allowable expenses for royalties and meals are permitted to the larger class of "health care providers," whereas the other allowable expenditures are limited to "health care professionals" directly.

Consistent with many industry codes of ethics, the conferences and seminars for which allowable expenditures may be made must be accredited by the Accreditation Council for Continuing Medical Education (ACCME) or a comparable organization (or be presented by an approved sponsor of continuing education and not a pharma company) and must offer continuing education credits, feature multiple presenters on scientific research, or be for the purpose of recommending or making policy.

Importantly, though the California Board of Pharmacy regulates medical device companies, this bill will not apply to manufacturers of medical devices.

SB 790 passed the California Senate by a vote of 23–13 but has further legislative hurdles before enactment. The bill is currently awaiting assignment to an Assembly Committee. If the Assembly Committee and the larger Assembly agree to pass the bill without additional amendment, California Governor Jerry Brown will then decide whether to enact the bill into law.

California is often a pioneer in state legislation, particularly involving healthcare and social services. If SB 790 is ultimately enacted, other states may enact or update current marketing regulations involving industry and healthcare professionals. Currently, seven states have regulations that limit or ban industry gifts to physicians or require tracking and reporting separately from the federal US Sunshine transparency provisions. While there are similarities in purpose and some requirements, often the scope of these varied marketing regulations differs in significant ways that create compliance challenges and exposures for companies and physicians. These differences raise the question whether transparency regulations should evolve to more uniform requirements or defer to federal transparency requirements.

This article is provided as a general informational service and it should not be construed as imparting legal advice on any specific matter.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.